Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Clinical Trials in Dallas, Texas

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia